<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1726-8958</journal-id>
<journal-title><![CDATA[Revista Médica La Paz]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Méd. La Paz]]></abbrev-journal-title>
<issn>1726-8958</issn>
<publisher>
<publisher-name><![CDATA[Colegio Médico de La Paz]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1726-89582023000200044</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[TERAPIA CELULAR EN ENFERMEDADES NEURODEGENERATIVAS: UNA OPCIÓN DE TRATAMIENTO INNOVADORA]]></article-title>
<article-title xml:lang="en"><![CDATA[CELL THERAPY IN NEURODEGENERATIVE DISEASES: AN INNOVATIVE TREATMENT OPTION]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Paz]]></surname>
<given-names><![CDATA[Helen]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carrasco]]></surname>
<given-names><![CDATA[Mireya]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mamani]]></surname>
<given-names><![CDATA[Reyna]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Velarde]]></surname>
<given-names><![CDATA[Jeaneth]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Patón]]></surname>
<given-names><![CDATA[Daniela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Quispe]]></surname>
<given-names><![CDATA[Teddy]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Amaru]]></surname>
<given-names><![CDATA[Ricardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,CONMED Unidad de Neurologia ]]></institution>
<addr-line><![CDATA[La Paz ]]></addr-line>
<country>Bolivia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,UMSA Facultad de Medicina Unidad de Biologia Celular]]></institution>
<addr-line><![CDATA[La Paz ]]></addr-line>
<country>Bolivia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Boliviano de Oncohematologia  ]]></institution>
<addr-line><![CDATA[La Paz ]]></addr-line>
<country>Bolivia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<volume>29</volume>
<numero>2</numero>
<fpage>44</fpage>
<lpage>50</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S1726-89582023000200044&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S1726-89582023000200044&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S1726-89582023000200044&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción. Las enfermedades neurodegenerativas se caracterizan por la degeneración y pérdida de células nerviosas que conllevan trastornos de disfunción cognitiva y sensoriomotora, enfermedades tales como la esclerosis múltiple (EM) y la enfermedad de Párkinson (EP) entre otras. Recientemente, se ha reportado sobre resultados prometedores de la terapia celular con Células Madre Mesenquimales, células con la capacidad de diferenciarse en células del tejido nervioso, en el tratamiento de enfermedades neurodegenerativas.  Objetivo. Evidenciar la utilidad de las células madre mesenquimales de médula ósea en el tratamiento de la esclerosis múltiple y enfermedad de Párkinson, como una posibilidad terapéutica en los tratamientos convencionales no favorables.  Material y métodos. Estudio longitudinal prospectivo que consideró pacientes con EM (n=2) y EP (n=2), quienes como tratamiento coadyuvante recibieron células madre mesenquimales de médula ósea mediante método de trasplante autólogo.  Resultados. Los pacientes recibieron entre 1 a 3 sesiones de reinfusión de células madre mesenquimales, cuyos seguimientos y evaluaciones periódicas reflejaron respuestas beneficiosas. Se observó mejoras representativas en las respectivas puntuaciones EDSS y UPDRS, así como, en la calidad de vida de los pacientes.  Conclusiones . La terapia celular con células madre mesenquimales de médula ósea constituye una posibilidad terapéutica factible para las enfermedades neurodegenerativas como la EM y EP.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction. Neurodegenerative disorders are characterized by a degeneration and loss of nerve cells leading to cognitive and sensorimotor dysfunction disorders, such as multiple sclerosis (MS) and Parkinson&#8217;s disease (PD) among others. Recently, it has been reported promising results of cell therapy employing Mesenchymal Stem Cells, cells with the ability to differentiate into nervous tissue cells, in the treatment of neurological diseases.  Objective. To expose the utility of bone marrow mesenchymal stem cells in the treatment of multiple sclerosis and Parkinson&#8217;s disease, as a therapeutic option in unfavorable treatment outcomes.  Material and methods. Prospective longitudinal study that included MS (n=2) and PD (n=2) patients, who received autologous transplantation of bone marrow mesenchymal stem cells as adjuvant treatment.  Results. Patients received autologous MSC therapy from 1 to 3 reinfusions, follow-up and regular evaluations reflected beneficial responses. Representative improvements concerning patients&#8217; respectively EDSS or UPDRS scores, as well as in their quality of life were observed.  Conclusions. Mesenchymal stem cells therapy constitutes a feasible therapeutic option for neurodegenerative disorders such as MS and PD.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Terapia Celular]]></kwd>
<kwd lng="es"><![CDATA[Células Madre Mesenquimales]]></kwd>
<kwd lng="es"><![CDATA[Esclerosis Múltiple]]></kwd>
<kwd lng="es"><![CDATA[Enfermedad de Párkinson]]></kwd>
<kwd lng="en"><![CDATA[Cell Therapy]]></kwd>
<kwd lng="en"><![CDATA[Mesenchymal Stem Cells]]></kwd>
<kwd lng="en"><![CDATA[Multiple sclerosis]]></kwd>
<kwd lng="en"><![CDATA[Parkinson&#8217;s disease]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shariati]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nemati]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sadeghipour]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Yaghoubi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Baghbani]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Javidi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mesenchymal stromal cells (MSCs) for neurodegenerative disease A promising frontier]]></article-title>
<source><![CDATA[European journal of cell biology]]></source>
<year>2020</year>
<volume>99</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sivandzade]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Cucullo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Regenerative stem cell therapy for neurodegenerative diseases an overview]]></article-title>
<source><![CDATA[International Journal of Molecular Sciences]]></source>
<year>2021</year>
<volume>22</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>2153</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Gioia]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Biella]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Citterio]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Rizzo]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Abati]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Nizzardo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neural stem cell transplantation for neurodegenerative diseases]]></article-title>
<source><![CDATA[International journal of molecular sciences]]></source>
<year>2020</year>
<volume>21</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>3103</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bravo-Gonzalez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarez-Roldan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Esclerosis multiple, perdida de funcionalidad y genero]]></article-title>
<source><![CDATA[Gaceta Sanitaria]]></source>
<year>2019</year>
<volume>33</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>177-84</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martinez-Altarriba]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos-Campoy]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Luna-Calcano]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Arrieta-Anton]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Revision de la Esclerosis Multiple (1) A proposito de un caso]]></article-title>
<source><![CDATA[SEMERGEN-Medicina de Familia]]></source>
<year>2015</year>
<volume>41</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>261-5</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Poewe]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Seppi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Tanner]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Halliday]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Brundin]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Volkmann]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Parkinson disease]]></article-title>
<source><![CDATA[Nature reviews Disease primers]]></source>
<year>2017</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-21</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lees]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hardy]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Revesz]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Parkinson's disease]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2009</year>
<volume>373</volume>
<numero>9680</numero>
<issue>9680</issue>
<page-range>2055-66</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fu]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Halim]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ju]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Luo]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Song]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mesenchymal stem cell migration and tissue repair]]></article-title>
<source><![CDATA[Cells]]></source>
<year>2019</year>
<volume>8</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>784</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sivandzade]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Cucullo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview]]></article-title>
<source><![CDATA[Int J Mol Sci]]></source>
<year>2021</year>
<volume>22</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[McKee]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bakshi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hakman]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Halassy]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mesenchymal stem cells Cell therapy and regeneration potential]]></article-title>
<source><![CDATA[Journal of tissue engineering and regenerative medicine]]></source>
<year>2019</year>
<volume>13</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1738-55</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nery]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Nascimento]]></surname>
<given-names><![CDATA[IC]]></given-names>
</name>
<name>
<surname><![CDATA[Glaser]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Bassaneze]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Krieger]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Ulrich]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human mesenchymal stem cells from immunophenotyping by flow cytometry to clinical applications]]></article-title>
<source><![CDATA[Cytometry Part A]]></source>
<year>2013</year>
<volume>83</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>48-61</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yao]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mesenchymal stem cells a potential therapeutic strategy for neurodegenerative diseases]]></article-title>
<source><![CDATA[European Neurology]]></source>
<year>2020</year>
<volume>83</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>235-41</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferrero]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Mazzini]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Rustichelli]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Gunetti]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mareschi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Testa]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients]]></article-title>
<source><![CDATA[Cell transplantation]]></source>
<year>2008</year>
<volume>17</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>255-66</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[H-J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stem cell potential in Parkinson's disease and molecular factors for the generation of dopamine neurons]]></article-title>
<source><![CDATA[Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease]]></source>
<year>2011</year>
<volume>1812</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-11</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaspari]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Roveda]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Scandellari]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Stecchi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An expert system for the evaluation of EDSS in multiple sclerosis]]></article-title>
<source><![CDATA[Artificial intelligence in medicine]]></source>
<year>2002</year>
<volume>25</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>187-210</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cao]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Peyrodie]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Boudet]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cavillon]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Agnani]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Hautecoeur]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Expanded Disability Status Scale (EDSS) estimation in multiple sclerosis from posturographic data]]></article-title>
<source><![CDATA[Gait &amp; posture]]></source>
<year>2013</year>
<volume>37</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>242-5</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<collab>Disease MDSTFoRSfPs</collab>
<article-title xml:lang=""><![CDATA[The unified Parkinson's disease rating scale (UPDRS) status and recommendations]]></article-title>
<source><![CDATA[Movement Disorders]]></source>
<year>2003</year>
<volume>18</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>738-50</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brusse]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Zimdars]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Zalewski]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Steffen]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Testing functional performance in people with Parkinson disease]]></article-title>
<source><![CDATA[Physical therapy]]></source>
<year>2005</year>
<volume>85</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>134-41</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amaru]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Miguez]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Quispe]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Quisbert]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mamani]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Terapia celular para el tratamiento de ulceras cronicas]]></article-title>
<source><![CDATA[Revista Medica La Paz]]></source>
<year>2016</year>
<volume>22</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>20-6</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Teddy]]></surname>
<given-names><![CDATA[Q-S]]></given-names>
</name>
<name>
<surname><![CDATA[Rafael]]></surname>
<given-names><![CDATA[R-F]]></given-names>
</name>
<name>
<surname><![CDATA[Valencia-Tola]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Daniela]]></surname>
<given-names><![CDATA[P-M]]></given-names>
</name>
<name>
<surname><![CDATA[Ricardo]]></surname>
<given-names><![CDATA[A-L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Terapia celular en quemadura de segundo grado profundo reporte de caso clinico]]></article-title>
<source><![CDATA[Cuadernos Hospital de Clinicas]]></source>
<year>2022</year>
<volume>63</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>50-4</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amaru]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Quispe]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Velarde]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mamani]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Carrasco]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Paton]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[TRASPLANTE AUTOLOGO DE PROGENITORES HEMATOPOYETICOS EN ENFERMEDADES LINFOPROLIFERATIVAS REPORTE DE 5 CASOS]]></article-title>
<source><![CDATA[Revista Medica La Paz]]></source>
<year>2019</year>
<volume>25</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>21-8</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Chia]]></surname>
<given-names><![CDATA[WC]]></given-names>
</name>
<name>
<surname><![CDATA[How]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
<name>
<surname><![CDATA[Tor]]></surname>
<given-names><![CDATA[YS]]></given-names>
</name>
<name>
<surname><![CDATA[Show]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
<name>
<surname><![CDATA[Looi]]></surname>
<given-names><![CDATA[QHD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benchtop isolation and characterization of small extracellular vesicles from human mesenchymal stem cells]]></article-title>
<source><![CDATA[Molecular biotechnology]]></source>
<year>2021</year>
<volume>63</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>780-91</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Araujo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Furlan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Salton]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Schmalfuss]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Rohsig]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Silla]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Isolation of human mesenchymal stem cells from amnion, chorion, placental decidua and umbilical cord comparison of four enzymatic protocols]]></article-title>
<source><![CDATA[Biotechnology letters]]></source>
<year>2018</year>
<volume>40</volume>
<page-range>989-98</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ahmadian-Moghadam]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Sadat-Shirazi]]></surname>
<given-names><![CDATA[M-S]]></given-names>
</name>
<name>
<surname><![CDATA[Zarrindast]]></surname>
<given-names><![CDATA[M-R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Therapeutic potential of stem cells for treatment of neurodegenerative diseases]]></article-title>
<source><![CDATA[Biotechnology letters]]></source>
<year>2020</year>
<volume>42</volume>
<page-range>1073-101</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Checkoway]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Lundin]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Kelada]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neurodegenerative diseases]]></article-title>
<source><![CDATA[IARC Sci Publ]]></source>
<year>2011</year>
<numero>163</numero>
<issue>163</issue>
<page-range>407-19</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santamaria]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Brandi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vitola]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
<name>
<surname><![CDATA[Grandi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrara]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Pischiutta]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer's mice]]></article-title>
<source><![CDATA[Cell Death &amp; Differentiation]]></source>
<year>2021</year>
<volume>28</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>203-18</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saito]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Kuang]]></surname>
<given-names><![CDATA[J-Q]]></given-names>
</name>
<name>
<surname><![CDATA[Bittira]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Khaldi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chiu]]></surname>
<given-names><![CDATA[RC-J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Xenotransplant cardiac chimera immune tolerance of adult stem cells]]></article-title>
<source><![CDATA[The Annals of thoracic surgery]]></source>
<year>2002</year>
<volume>74</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>19-24</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chopp]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[XH]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Spinal cord injury in rat treatment with bone marrow stromal cell transplantation]]></article-title>
<source><![CDATA[Neuroreport]]></source>
<year>2000</year>
<volume>11</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>3001-5</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Genc]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Bozan]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Genc]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Genc]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stem cell therapy for multiple sclerosis]]></article-title>
<source><![CDATA[Tissue Engineering and Regenerative Medicine]]></source>
<year>2019</year>
<page-range>145-74</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Staff]]></surname>
<given-names><![CDATA[NP]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[DT]]></given-names>
</name>
<name>
<surname><![CDATA[Singer]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases]]></article-title>
<source><![CDATA[Mayo Clin Proc]]></source>
<year>2019</year>
<volume>94</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>892-905</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yasuhara]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Kameda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sasaki]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Tajiri]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Date]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cell Therapy for Parkinson's Disease]]></article-title>
<source><![CDATA[Cell Transplant]]></source>
<year>2017</year>
<volume>26</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1551-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
